Want to see DNA full AI Analyst Report?
Ginkgo Bioworks Holdings (DNA) Income Statement
Ginkgo Bioworks Holdings Income Statement
Last quarter (Q2 2026), Ginkgo Bioworks Holdings's total revenue was $20.16M, a decrease of 59.37% from the same quarter last year. In Q2, Ginkgo Bioworks Holdings's net income was $-46.71M. See Ginkgo Bioworks Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 170.16M | $ 227.04M | $ 251.46M | $ 477.71M | $ 313.84M | |
| $ 138.63M | $ 188.49M | $ 197.45M | $ 273.49M | $ 184.15M | |
| $ 453.91M | $ 748.25M | $ 1.06B | $ 2.48B | $ 2.01B | |
| Depreciation and Amortization | $ 58.99M | $ 63.02M | $ 71.55M | $ 42.55M | $ 29.08M |
| $ -254.61M | $ -484.39M | $ -821.29M | $ -2.08B | $ -1.81B | |
| $ -315.28M | $ -559.76M | $ -864.41M | $ -2.21B | $ -1.83B | |
| $ 1.68M | $ 12.25M | $ -28.53M | $ 87.55M | $ -9.65M | |
| $ -313.60M | $ -547.51M | $ -892.94M | $ -2.12B | $ -1.84B | |
| $ -312.76M | $ -547.03M | $ -892.87M | $ -2.10B | $ -1.83B | |
| Per Share Metrics | |||||
| Basic EPS | $ -5.64 | $ -10.54 | $ -18.37 | $ -50.15 | $ -53.83 |
| Diluted EPS | $ -5.64 | $ -10.54 | $ -18.40 | $ -50.20 | $ -55.53 |
| Weighted Average Shares Outstanding | 55.46M | 51.89M | 48.53M | 41.93M | 32.95M |
| Weighted Average Shares Outstanding (Diluted) | 55.46M | 51.89M | 48.61M | 42.00M | 34.01M |
Currency in USD